Zepteon, Inc. is a privately held corporation founded in 2012 that has developed first in class chromatography resins capable of separating antibodies with specific sugar structures (nonfucosylated) that are more potent against diseases like cancer. This technology enables more effective therapeutics and can reduce cost and dosing requirements.
| Website | https://www.zepteon.com/ |
| Revenue | $7 million |
| Employees | 4 (0 on RocketReach) |
| Founded | 2012 |
| Phone | (877) 222-5108 |
| Technologies |
JavaScript
,
PHP
,
Google Analytics
+1 more
(view full list)
|
| Industry | Biotechnology Research, Chemicals, Petrochemicals, Glass & Gases, Biotechnology, Manufacturing, Science and Engineering, Health Care, Wellness |
| Keywords | Chromatography Resins, Biotechnology, Pharmaceutical, Therapeutic Antibodies, Downstream Processing, Bioseparations, Bioprocessing, Affinity Chromatography, Process Development, Drug Development, Cancer Treatment, Immuno-Oncology, Analytical Chemistry |
| Competitors | Deloitte, IBM, Cognizant, Capgemini, Accenture, Hewlett Packard Enterprise, Tata Consultancy Services, Wipro, Infosys, Syntel Inc +44 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 325414 Companies |
Looking for a particular Zepteon, Inc. employee's phone or email?
The Zepteon, Inc. annual revenue was $7 million in 2026.
Zepteon, Inc. is based in Boston, Massachusetts.
The NAICS codes for Zepteon, Inc. are [32541, 32, 3254, 325, 325414].
The SIC codes for Zepteon, Inc. are [28, 283].